Insulin and glucagon levels in fulminant hepatic failure in man. 1991

F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
Infectious Diseases Department, University of Parma, Italy.

The behavior of insulin and glucagon and related metabolic substrates was assayed in plasma of patients with fulminant hepatic failure. All 12 subjects were provided the same nutritional support. High levels of insulin and glucagon were present at all times and no difference was observed between surviving patients (four) and those who died (8). Elevated values for branched-chain and aromatic amino acids as well as alanine were present. Statistically significant lower levels of aromatic amino acids and consequently a greater branched chain-aromatic amino acid ratio was found in surviving vs nonsurviving patients. A significantly greater level of alpha-fetoprotein was found in patients who survived as compared to those who died.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
October 1979, Gastroenterologia Japonica,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
May 1990, Journal of hepatology,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
January 1991, Digestive diseases and sciences,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
April 1984, The American journal of medicine,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
January 1992, Journal of gastroenterology and hepatology,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
June 1991, Digestive diseases and sciences,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
August 1994, Metabolism: clinical and experimental,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
January 1990, Digestive diseases (Basel, Switzerland),
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
August 1974, Journal of the Indian Medical Association,
F Fiaccadori, and G Pedretti, and C Ferrari, and P Pizzaferri, and O Riggio, and N Orlandi, and A Pezzarossa
December 2003, Current treatment options in gastroenterology,
Copied contents to your clipboard!